Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $272,924 | +124.5% | 40,195 | +65.7% | 0.00% | – |
| Q1 2023 | $121,568 | -62.6% | 24,265 | -63.6% | 0.00% | – |
| Q4 2022 | $325,257 | +82.7% | 66,651 | +438.6% | 0.00% | – |
| Q3 2022 | $178,000 | -75.4% | 12,375 | -72.3% | 0.00% | – |
| Q4 2021 | $724,000 | +38.4% | 44,673 | +144.0% | 0.00% | – |
| Q3 2021 | $523,000 | +139.9% | 18,311 | +154.2% | 0.00% | – |
| Q1 2021 | $218,000 | -78.6% | 7,204 | -65.0% | 0.00% | -100.0% |
| Q4 2020 | $1,020,000 | +200.0% | 20,607 | +132.5% | 0.00% | – |
| Q3 2020 | $340,000 | +10.0% | 8,864 | +23.9% | 0.00% | – |
| Q2 2020 | $309,000 | – | 7,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |